A Phase 2a Clinical Trial to Evaluate the Safety and Immunogenicity of a Prime-Boost Vaccine Regimen of pGA2/JS7 DNA and MVA/HIV62, in Healthy, HIV Uninfected Vaccinia-Naive Adult Participants
To assess the safety and tolerability of a prime-boost regimen of pGA2/JS7 DNA vaccine and MVA/HIV62 vaccine, in healthy, HIV-uninfected, vaccinia-naive individuals.
